Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Beclomethasone in Atopic Children
NCT01113489Phase 3Completed
- Sponsor
- Fondazione Monasterio
- Start
- Apr 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and allergic rhinitis (AR) comparing Beclomethasone with Placebo (2 arms). Primary endpoint: Change in level of oral and nasal fractional exhaled nitric oxide at 4 weeks. Started Apr 2010; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01113489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113489.